Defining disease processes by their cellular and molecular signatures has enabled molecular diagnosis and the development of targeted therapies, and advances in genomics offer promise for earlier disease detection and possibly molecular prevention. The field of molecular imaging is embracing these advances and is using a diverse set of molecular imaging strategies to interrogate disease states and physiology.


In early February, the Centers for Medicare and Medical Services (CMS) announced a final rule necessary to implement requirements laid out in the Affordable Care Act Sunshine Rule that will increase public disclosure of financial relationships between drug/device manufacturers, and physicians and teaching hospitals.

For better treatment planning during cardiac resynchronization therapy (CRT), Toshiba America Medical System Inc.’s Activation Imaging is the company’s latest addition to its 3-D Wall Motion Tracking software. Activation Imaging is an U.S. Food and Drug Administration (FDA)-cleared, proprietary technology available on the Aplio Artida cardiovascular ultrasound system.

 

Activation Imaging Technology

Absorb Bioresorbable Vascular Scaffold

March 14, 2013 — invendo medical announced it has entered the U.S. market with the first installation of systems at two renowned GI endoscopy centers, NYU Langone Medical Center and New York-Presbyterian Hospital/Columbia University Medical Center.

Subscribe Now